249 related articles for article (PubMed ID: 9425015)
1. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22.
D'Urso D; Prior R; Greiner-Petter R; Gabreëls-Festen AA; Müller HW
J Neurosci; 1998 Jan; 18(2):731-40. PubMed ID: 9425015
[TBL] [Abstract][Full Text] [Related]
2. Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction.
Tobler AR; Notterpek L; Naef R; Taylor V; Suter U; Shooter EM
J Neurosci; 1999 Mar; 19(6):2027-36. PubMed ID: 10066256
[TBL] [Abstract][Full Text] [Related]
3. Rer1 and calnexin regulate endoplasmic reticulum retention of a peripheral myelin protein 22 mutant that causes type 1A Charcot-Marie-Tooth disease.
Hara T; Hashimoto Y; Akuzawa T; Hirai R; Kobayashi H; Sato K
Sci Rep; 2014 Nov; 4():6992. PubMed ID: 25385046
[TBL] [Abstract][Full Text] [Related]
4. PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells.
Colby J; Nicholson R; Dickson KM; Orfali W; Naef R; Suter U; Snipes GJ
Neurobiol Dis; 2000 Dec; 7(6 Pt B):561-73. PubMed ID: 11114256
[TBL] [Abstract][Full Text] [Related]
5. Peripheral myelin protein 22 modulates store-operated calcium channel activity, providing insights into Charcot-Marie-Tooth disease etiology.
Vanoye CG; Sakakura M; Follis RM; Trevisan AJ; Narayan M; Li J; Sanders CR; Carter BD
J Biol Chem; 2019 Aug; 294(32):12054-12065. PubMed ID: 31213528
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases.
Shames I; Fraser A; Colby J; Orfali W; Snipes GJ
J Neuropathol Exp Neurol; 2003 Jul; 62(7):751-64. PubMed ID: 12901701
[TBL] [Abstract][Full Text] [Related]
7. Colocalization Analysis of Peripheral Myelin Protein-22 and Lamin-B1 in the Schwann Cell Nuclei of Wt and TrJ Mice.
Di Tomaso MV; Vázquez Alberdi L; Olsson D; Cancela S; Fernández A; Rosillo JC; Reyes Ábalos AL; Álvarez Zabaleta M; Calero M; Kun A
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327648
[TBL] [Abstract][Full Text] [Related]
8. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies.
Naef R; Suter U
Neurobiol Dis; 1999 Feb; 6(1):1-14. PubMed ID: 10078969
[TBL] [Abstract][Full Text] [Related]
9. Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22.
Tobler AR; Liu N; Mueller L; Shooter EM
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):483-8. PubMed ID: 11752407
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy.
Notterpek L; Shooter EM; Snipes GJ
J Neurosci; 1997 Jun; 17(11):4190-200. PubMed ID: 9151736
[TBL] [Abstract][Full Text] [Related]
11. Regulation of myelin-specific gene expression. Relevance to CMT1.
Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
[TBL] [Abstract][Full Text] [Related]
12. Subcellular diversion of cholesterol by gain- and loss-of-function mutations in PMP22.
Zhou Y; Borchelt D; Bauson JC; Fazio S; Miles JR; Tavori H; Notterpek L
Glia; 2020 Nov; 68(11):2300-2315. PubMed ID: 32511821
[TBL] [Abstract][Full Text] [Related]
13. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
[TBL] [Abstract][Full Text] [Related]
14. Central Alteration in Peripheral Neuropathy of Trembler-J Mice: Hippocampal pmp22 Expression and Behavioral Profile in Anxiety Tests.
Damián JP; Vázquez Alberdi L; Canclini L; Rosso G; Bravo SO; Martínez M; Uriarte N; Ruiz P; Calero M; Di Tomaso MV; Kun A
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921657
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.
Sancho S; Young P; Suter U
Brain; 2001 Nov; 124(Pt 11):2177-87. PubMed ID: 11673320
[TBL] [Abstract][Full Text] [Related]
16. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
[TBL] [Abstract][Full Text] [Related]
17. Pmp22 mutant allele-specific siRNA alleviates demyelinating neuropathic phenotype in vivo.
Lee JS; Chang EH; Koo OJ; Jwa DH; Mo WM; Kwak G; Moon HW; Park HT; Hong YB; Choi BO
Neurobiol Dis; 2017 Apr; 100():99-107. PubMed ID: 28108290
[TBL] [Abstract][Full Text] [Related]
18. Exposure at the cell surface is required for gas3/PMP22 To regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases.
Brancolini C; Edomi P; Marzinotto S; Schneider C
Mol Biol Cell; 2000 Sep; 11(9):2901-14. PubMed ID: 10982389
[TBL] [Abstract][Full Text] [Related]
19. Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot-Marie-Tooth type 1A.
Hanemann CO; D'Urso D; Gabreëls-Festen AA; Müller HW
Brain; 2000 May; 123 ( Pt 5)():1001-6. PubMed ID: 10775544
[TBL] [Abstract][Full Text] [Related]
20. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]